These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


354 related items for PubMed ID: 12054679

  • 1. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T.
    Biochem Biophys Res Commun; 2002 May 24; 293(5):1458-65. PubMed ID: 12054679
    [Abstract] [Full Text] [Related]

  • 2. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T.
    Mol Pharmacol; 2001 Oct 24; 60(4):656-65. PubMed ID: 11562426
    [Abstract] [Full Text] [Related]

  • 3. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T.
    Mol Pharmacol; 2004 Apr 24; 65(4):832-41. PubMed ID: 15044612
    [Abstract] [Full Text] [Related]

  • 4. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
    Zhou CH, Wu XH, Wu YQ.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):55-60. PubMed ID: 19486902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.
    Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, Tamaki T.
    Acta Pharmacol Sin; 2004 Aug 01; 25(8):977-85. PubMed ID: 15301727
    [Abstract] [Full Text] [Related]

  • 11. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
    Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kübler W, Kreuzer J.
    Arterioscler Thromb Vasc Biol; 2000 Apr 01; 20(4):940-8. PubMed ID: 10764657
    [Abstract] [Full Text] [Related]

  • 12. Age-related differences in MAP kinase activity in VSMC in response to glucose or TNF-alpha.
    Li M, Mossman BT, Kolpa E, Timblin CR, Shukla A, Taatjes DJ, Fukagawa NK.
    J Cell Physiol; 2003 Dec 01; 197(3):418-25. PubMed ID: 14566971
    [Abstract] [Full Text] [Related]

  • 13. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
    Won SM, Park YH, Kim HJ, Park KM, Lee WJ.
    Exp Mol Med; 2006 Oct 31; 38(5):525-34. PubMed ID: 17079869
    [Abstract] [Full Text] [Related]

  • 14. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R, Ahmed S, Malemud CJ, Goldberg VM, Haqqi TM.
    J Orthop Res; 2003 Jan 31; 21(1):102-9. PubMed ID: 12507586
    [Abstract] [Full Text] [Related]

  • 15. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts.
    Li JM, Cui TX, Shiuchi T, Liu HW, Min LJ, Okumura M, Jinno T, Wu L, Iwai M, Horiuchi M.
    Arterioscler Thromb Vasc Biol; 2004 Jan 31; 24(1):80-4. PubMed ID: 14592853
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
    Li JM, Wheatcroft S, Fan LM, Kearney MT, Shah AM.
    Circulation; 2004 Mar 16; 109(10):1307-13. PubMed ID: 14993144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.